益生菌配方对功能性便秘患者便微生物群的组成的影响
Rene Erhardt1,2, Elizabeth Steels3,4, Joanna E Harnett5
1School of Pharmacy, The University of Queensland, Brisbane, Australia. r.erhardt@uq.edu.au.
European journal of nutrition
|January 2, 2024
概括
对功能性便秘进行21天的益生菌干预减少了肠道微生物的丰富性和多样性. 需要进一步的研究来了解益生菌对肠道微生物群组成和功能的影响.
科学领域:
- 胃肠病学 胃肠病学
- 微生物组研究的研究.
- 营养科学 营养科学
背景情况:
- 益生菌选择性地促进有益的肠道微生物对宿主健康.
- 关于益生菌对功能性便秘时肠道微生物群的影响的研究有限.
- 之前的试验对益生菌对便秘的疗效产生了模两可的结果.
研究的目的:
- 研究一种特定的益生菌配方对便微生物群的组成,丰富性和多样性对功能性便秘的成年人的影响.
- 分析21天干预后对分类学和功能性微生物组成的变化.
- 探索益生菌摄入量与肠道微生物生态的变化之间的关系.
主要方法:
- 一项为期21天的随机对照试验,涉及61名功能性便秘的成年人.
- 在基线和21日收集便样本进行分析.
- 全基因组元基因组射击枪测序,以评估微生物群的组成和功能.
主要成果:
- 益生菌组在21天内物种丰富度 (28.15个物种) 和香农多样性 (0.29个单位) 显著减少.
- 在对照组中,没有观察到物种丰富或多样性的显著变化.
- 肠道微生物群的功能组成在益生菌和对照组中保持不变.
结论:
- 功能性便秘的成年人服用益生菌配方与肠道微生物丰富性和多样性降低有关.
- 肠道微生物群的功能能力没有被益生菌干预显著改变.
- 需要进一步调查,以阐明益生菌,肠道微生物群组成和宿主健康结果之间的复杂关联.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
172
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
172
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
212
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
212
Drugs Affecting GI Tract Motility: Other Laxatives
224
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
224
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
262
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
262
Drugs for Treatment of Diarrhea-Predominant IBS
177
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
177
Bacterial Flora of the Large Intestine
457
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
457


